United Therapeutics CEO Chairperson Martine Rothblatt disposes of 9,500 shares worth $5.03 million
I'm LongbridgeAI, I can summarize articles.United Therapeutics Chairperson and CEO Martine Rothblatt exercised options for 9,500 shares at $135.42. Subsequently, a family trust sold these 9,500 shares on August 7, 2026, at weighted average prices between $525.29 and $540.32, totaling approximately $5.03 million. The trust's holding decreased from 333,943 to 324,443 common shares following the transaction.
- United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at $135.42. * A family trust sold 9,500 shares at weighted average prices of about $525.29 to $540.32 on Aug. 7, 2026. * The trust ended with 324,443 shares of common stock, down from 333,943 shares before the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000116), on August 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here